Amphetamine controlled release, prodrug, and abuse-deterrent dosage forms
US12208068B2 · kind B2 · utility
0Cited by
14References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2023 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | Apr 4, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention also relates to processes for producing abuse deterrent pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.